Edition:
United States

People: Immunomedics Inc (IMMU.OQ)

IMMU.OQ on NASDAQ Stock Exchange Global Market

16.65USD
22 Apr 2019
Change (% chg)

-- (--)
Prev Close
$16.65
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
901,590
52-wk High
$27.32
52-wk Low
$11.57

Garone, Michael 

Mr. Michael R. Garone is no longer Vice President - Finance of the Company effective May 18, 2019. He joined Immunomedics as Vice President, Finance and Chief Financial Officer in June 2016 and assumed the additional role of Principal Executive Officer in July 2017. Previously, from August 2007 through June 2016, he was the Chief Financial Officer of Emisphere Technologies, Inc., a commercial stage, specialty pharmaceutical company, where he also served as Corporate Secretary since October 2008 and as Interim Chief Executive Officer from February 2011 until September 2012. Before Emisphere, Mr. Garone served as Interim Chief Executive Officer and Chief Financial Officer of Astralis, Ltd. Prior to that, he served 20 years at AT&T, where he held several positions, including Chief Financial Officer of AT&T Alascom. Mr. Garone received an MBA from Columbia University and a BA in Mathematics from Colgate University.

Basic Compensation

Total Annual Compensation, USD 390,000
Restricted Stock Awards, USD --
Long-Term Incentive Plans, USD --
All Other, USD --
Fiscal Year Total, USD 390,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --